Navigation Links
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
Date:10/31/2008

"As a result of prudent cash control, we reconfirm that the cash burn for the year ended December 31, 2008 will remain at the lower end of $25 to $30 million guidance provided earlier this year," said Stuart Grant, BioCryst's Chief Financial Officer. "We have implemented strategic initiatives, including a recent 20 percent reduction in our workforce, to focus the Company's resources on the execution of our late-stage clinical trials and the development of our most promising pre-clinical compounds. We have full funding of our peramivir program through Phase 2 clinical trials from HHS and a strong cash position that will allow us to execute on our plan without depending on the capital markets."

"We have recently made significant advancements in our clinical programs and are encouraged by the positive peramivir efficacy data reported in the Phase 2 study we conducted in subjects with influenza requiring hospitalization, and the Phase 2 study in subjects with acute uncomplicated influenza conducted by our partner, Shionogi & Co., Ltd.," said Jon Stonehouse, President and Chief Executive Officer of BioCryst. "Over the next year, we have several key value-driving milestones for both our peramivir and PNP programs and remain committed to advancing our products towards market."

Corporate Update

-- A poster entitled "A Double-Blind, Placebo-Controlled Study of

Intravenous Peramivir in Acute Influenza Patients" was presented at

the 48th Annual Interscience Conference on Antimicrobial Agents and

Chemotherapy (ICAAC), detailing the results of a Shionogi & Co.,

Ltd.-sponsored, placebo-controlled, Phase 2 study of intravenous (i.v.)

peramivir, a neuraminidase inhibitor, in outpatients with acute,

uncomplicated influenza. The study met its primary endpoint of time to

alleviation of symptoms for both the 300 mg dose (p=0.0046) and 600 mg

dose (p=0.0046) (hazard ratios we
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
2. BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
3. BioCryst to Present at the JMP Healthcare Focus Conference
4. BioCryst to Present at UBS 2008 Global Life Sciences Conference
5. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
6. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
7. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
8. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
9. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
10. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
11. BioCryst to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... The College of New Rochelle announced today ... Mid-Hudson Region to be designated as a START-UP NY ... qualified “high-technology” businesses that align with the College’s academic ... been selected for the START-UP NY program and extremely ... economic development in New York by growing business and ...
(Date:8/21/2014)... Aug. 21, 2014  Four-dimensional (4-D) printing develops ... on external stimuli such as changes in temperature. ... disruptive effect in multiple industries.  In the near ... by printing objects ranging from human organs to ... Logo - http://photos.prnewswire.com/prnh/20140820/138289 ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, the world's first ... available for purchase in Australia and New Zealand, and the ... works is, if you think about the definition of aging, ... renewal within your body. If you think about the definition ... renewal. What RENU 28 does is it works with these ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
Breaking Biology Technology:The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4RENU 28 Skin Care Now Available in Australia and New Zealand 2Neurotrope To Host Conference Call 2
... Batchelor, Lynn Jordan, and Ed Alderman , ... 01748 , Karen Heins and Olaf ... 100 Cummings Center, Suite 107J, Beverly, MA 01915 , ... The goal for plasmid purification is isolation of nucleic acid from cellular material. ...
... Larry Simonson and Lynn Jordan , ... Laboratory, Hopkinton, Massachusetts, USA , ... work in 96 well microplates was commonly carried out using manual ... grown, automated liquid handling has become a necessity for most laboratories. ...
... and Lynn Jordan , Caliper ... Introduction , ... Sciclone Advanced Liquid Handler (ALH). This device is designed to permit individually ... 384 well microplates for purposes of liquid transfer (tertiary dispensing). It can ...
Cached Biology Technology:High Throughput Plasmid DNA Preparation Using A Magnetic Bead Kit On An Automated Workstation 2High Throughput Plasmid DNA Preparation Using A Magnetic Bead Kit On An Automated Workstation 3384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler 2384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler 3384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler 4Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 2Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 3Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 4Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 5
(Date:8/21/2014)... (ANU) team has successfully replicated one of the crucial ... powered by sunlight which could manufacture hydrogen as a ... It is an exciting prospect to use them to ... Dr Kastoori Hingorani, from the ARC Centre of Excellence ... Biology. , Hydrogen offers potential as a zero-carbon replacement ...
(Date:8/20/2014)... N.Y. In a study of 158 pregnant teenagers ... the craving and intentional consumption of ice, cornstarch, vacuum ... reports a new Cornell study. , Moreover, such teens ... who did not eat nonfood substances. , Pregnant teens, ... hemoglobin, which can lead to iron deficiency and anemia. ...
(Date:8/20/2014)... Tbingen, Arizona State University, the Wellcome Trust Sanger Institute ... TPH) isolated Mycobacterium pinnipedii from skeletons found ... The pathogen is a relative of the TB bacterium ... humans today. These researchers assume that seals carried the ... to sea lions was unexpected" comments Sebastien Gagneux, from ...
Breaking Biology News(10 mins):Water and sunlight the formula for sustainable fuel 2Pica in pregnant teens linked to low iron 2
... when it comes to starting a business. Thats the case ... invented a trading card game, Elementeo, that aims to teach ... the 235th National Meeting of the American Chemical Society in ... other 14-year olds play on their Xbox, this precocious CEO ...
... 8, 2008 More good news for pistachio fans! According ... Conference in San Diego, snacking on pistachios has proved once ... by significantly reducing inflammation in the body, a prominent cardiovascular ... one cause of death in the U.S., with millions more ...
... two Queens scientists has resulted in an exciting new method ... weapons and pesticides. Recently completed testing by an independent ... greater than 99 per cent effective when used on the ... in solution, full destruction of all three agents was achieved ...
Cached Biology News:14-year-old CEO makes chemistry a game with 'Elementeo' 2Nutrition research unveiled this week shows pistachios are smart for the heart 2Nutrition research unveiled this week shows pistachios are smart for the heart 3Nutrition research unveiled this week shows pistachios are smart for the heart 4Queen's develops safe 'green' decontamination method 2
Superior homology search software - in all the flavours of blast, with increased sensitivity and speed. Free windows version for academic use....
Full service including gene cloning, protien expression and purification of 1 liter culture....
Protein 3D structure prediction, via threading. Easy to use....
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
Biology Products: